Phase 3

CYB003"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"

Sponsor:

Cybin IRL Limited

Code:

NCT06564818

Conditions

Major Depressive Disorder

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

CYB003

Psychological Support

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-26. This information was provided to ClinicalTrials.gov by Cybin IRL Limited on 2026-08-12.